Vorsitz: N. Frey (Kiel), V. Regitz-Zagrosek (Berlin)
(V1594) |
Increased Adipose Tissue Catabolism, Insulin Resistance and Chronic Heart Failure |
|
T. Szabó, E. Postrach, A. Mähler, S. D. Anker, M. Boschmann, W. Döhner (Berlin) |
(V1595) | The role of HMGB1 in the development of diabetic cardiomyopathy |
|
H. C. Volz, C. Seidel, D. Laohachewin, F. Lasitschka, M. E. Bianchi, Z. Kaya, A. Bierhaus, H. A. Katus, M. Andrassy (Heidelberg; Milano, IT) |
(V1596) | Metabolic Imbalance in Chronic Heart Failure – The Role Of Adiponectin In Disease Progression And Symptomatic Status |
|
T. Szabó, M. Bauer, S. von Haehling, A. Sandek, A. Pfeiffer, A. Flyvbjerg, S. D. Anker, W. Döhner (Berlin; Aarhus, DK) |
(V1597) | Anti-inflammatory treatment reverses myocardial insulin resistance in mice lacking PPARγ in cardiomyocytes |
|
E. Caglayan, K. Müller-Wellensiek, M. Kreissl, M. Vantler, U. Flögel, K.-D. Schlüter, W. Hsueh, S. Rosenkranz (Köln, Würzburg, Düsseldorf, Gießen; Houston, US) |
(V1598) | Impaired Mitochondrial Dynamics: A Novel Mechanism for Lipotoxic Heart Disease |
|
H. Bugger, H. Gordon, C. Kikani, C. Sloan, G. Sparagna, J. Rutter, J. E. Schaffer, E. Abel (Freiburg im Breisgau; Salt Lake City, Boulder, St. Louis, US) |
(V1599) | Association of glucose metabolism with diastolic function along the diabetic continuum |
|
R. Stahrenberg, F. Edelmann, M. Mende, A. Kockskämper, H.-D. Düngen, M. Scherer, M. M. Kochen, L. Binder, C. Herrmann-Lingen, L. Schönbrunn, G. Gelbrich, G. Hasenfuß, B. Pieske, R. Wachter (Göttingen, Leipzig, Berlin; Graz, AT) |